|
TODAY'S TOPIC
Postmenopausal Bleeding and Endometrial Cancer
|
| You have probably heard that light spotting after menopause is nothing to worry about. Today’s three claims explain why that sentence needs a second half. |
|
CLAIM 01
“Bleeding after menopause is the most common warning sign of endometrial cancer.”
|
| VERDICT TRUTH |
|
Endometrial cancer is the most common gynecologic cancer in the United States. It has one symptom that shows up far more than any other. About 90% of women with endometrial cancer have postmenopausal bleeding, which ACOG defines as bleeding from the uterus 12 or more months after the final period. Incidence has been rising steadily for decades. A bleed after that point is a reason for an evaluation. |
|
THE RESEARCH
|
● Fatal heart attack at 71.
Her father took statins for 9 years.
Every visit he told his doctor the muscle pain was getting worse.
Every visit the doctor said: “That’s normal.”
He died of a heart attack at 71.
Cholesterol… Perfect.
Drug… Worked exactly as designed.
But he died anyway.
His daughter is a heart health researcher. That funeral was the day she started asking the questions her industry didn’t want her to ask.
What she found has a name.
Almost no doctor screens for it. Almost no patient has heard of it.
She finally said it on camera:
If your parents took statins, or you do, or someone you love does…
Sincerely,
P.S. Watch her face when she gets to the part about her father. She’s not a person who shows emotion. It still gets her → Almost no doctor screens for this
|
CLAIM 02
“Postmenopausal bleeding usually means cancer.”
|
| VERDICT MYTH |
|
The bleeding is the signal, and most of the time the cause is benign. Between 1% and 14% of women with postmenopausal bleeding are diagnosed with endometrial cancer, depending on age and risk factors. The average sits below 10%. That is the reason for the evaluation: it separates the minority with cancer from the majority without. |
|
THE RESEARCH
|
|
CLAIM 03
“An ultrasound alone is enough to rule out cancer when bleeding starts after menopause.”
|
| VERDICT IT'S COMPLICATED |
|
For years, a thin lining on ultrasound counted as the all-clear. ACOG’s updated guidance changes the default. ACOG now recommends transvaginal ultrasound plus endometrial tissue sampling as part of the initial evaluation in most patients, citing data that 5% to 12% of cancers may not be diagnosed during the initial evaluation. Ultrasound alone remains an option for select patients, including some people with a single episode of bleeding, a fully visualized endometrial lining no thicker than 4 mm, and no strong risk factors. Continued or recurrent bleeding needs re-evaluation, even after a reassuring first scan. |
|
WHERE THE EVIDENCE SPLITS
|
|
GO DEEPER
What counts as a warning sign?
The American Cancer Society explains which bleeding, spotting, and discharge symptoms should be checked after menopause.
Read the ACS guide →
|
|
THE BOTTOM LINE
Most of the time the answer is benign.
The only way to know is to ask.
|
|
●
Which verdict surprised you most?
|
||
| One tap. It decides what we dig into next. | ||
|
||
|
||
|
